Epione Therapeutics

About Epione Therapeutics

Epione is a biopharmaceutical company founded in 2023 in Utrecht (NL) ready to enter the final pre-clinical phase. Epione develops injectable biomaterial-based formulations of existing drugs for long term pain relief in chronic musculoskeletal disease. At the basis of the Epione pipeline is a versatile biomaterial platform with unique characteristics enabling up to 12 months of both small molecule and protein-based drug release. Based on extensive preclinical data sets, Epione’s leading product based on the local release of a COX-2 inhibitor is close to first-in-human clinical trials in knee osteoarthritis and chronic low back pain.

Address

• Headquarters

  Stadhouderslaan 593583JD UtrechtUtrecht, Netherlands

Team by function

Based on 1 public job profiles as of 4 September 2026.

• Research / R&D1